| 1 | [SID90341534] | Active | Potency | 0.006 | qHTS Validation Assay for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails [AID488953, Type: confirmatory] | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] |  View X | Row No. | 1 | | Structure | 
| | Substance | | | SID | 90341534 | | CID | 2907 | | Outcome | Active | | Potency | 0.006 [uM] | | BioAssay | qHTS Validation Assay for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails | | AID | 488953 | | BioAssay type | confirmatory | | Target | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] | | PubMed | | | Data Table | |
|
| 2 | [SID103171472] | Active | IC50 | 8.79 | Cytotoxicity against human HL60 cells by MTT assay [AID526308, Type: Literature] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103171472 | | CID | 2907 | | Outcome | Active | | IC50 | 8.79 [uM] | | BioAssay | Cytotoxicity against human HL60 cells by MTT assay | | AID | 526308 | | BioAssay type | Literature | | Target | | | PubMed | 20850303 | | Data Table | |
|
| 3 | [SID90341534] | Active | Potency | 17.7828 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 90341534 | | CID | 2907 | | Outcome | Active | | Potency | 17.7828 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table | |
|
| 4 | [SID103171472] | Active | IC50 | 37.6 | In vitro cytotoxicity against BALB/c 3T3 cells [AID41567, Type: Literature] | | View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103171472 | | CID | 2907 | | Outcome | Active | | IC50 | 37.6 [uM] | | BioAssay | In vitro cytotoxicity against BALB/c 3T3 cells | | AID | 41567 | | BioAssay type | Literature | | Target | | | PubMed | 7877150 | | Data Table | |
|
| 5 | [SID103171472] | Active | LC50 | 37.6 | In vitro cytotoxicity in BALB/c3T3 mouse embryo fibroblasts. [AID41575, Type: Literature] | | View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103171472 | | CID | 2907 | | Outcome | Active | | LC50 | 37.6 [uM] | | BioAssay | In vitro cytotoxicity in BALB/c3T3 mouse embryo fibroblasts. | | AID | 41575 | | BioAssay type | Literature | | Target | | | PubMed | 1995881 | | Data Table | |
|
| 6 | [SID103171472] | Active | LC50 | 37.6 | In vitro cytotoxicity was evaluated in mouse embryo BALB/c 3T3 cells [AID3372, Type: Literature] | | View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103171472 | | CID | 2907 | | Outcome | Active | | LC50 | 37.6 [uM] | | BioAssay | In vitro cytotoxicity was evaluated in mouse embryo BALB/c 3T3 cells | | AID | 3372 | | BioAssay type | Literature | | Target | | | PubMed | 9873412 | | Data Table | |
|
| 7 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model Lieberman Plasma Cell No. 1 (LPC-1) (intraperitoneal) in unknown mice [AID344, Type: other] | | View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model Lieberman Plasma Cell No. 1 (LPC-1) (intraperitoneal) in unknown mice | | AID | 344 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 8 | [SID141705] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice [AID256, Type: other] | | View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 141705 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice | | AID | 256 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 9 | [SID141706] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice [AID256, Type: other] | | View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 141706 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice | | AID | 256 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 10 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia resistant to Methyl-GAG; NSC 32946 (subcutaneous) in B6D2F1 (BDF1) mice [AID306, Type: other] | | View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia resistant to Methyl-GAG; NSC 32946 (subcutaneous) in B6D2F1 (BDF1) mice | | AID | 306 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 11 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia resistant to 6-MP and 6-Thioguanine; NSC 755, NSC 752 (intraperitoneal) in B6D2F1 (BDF1) mice [AID308, Type: other] | | View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia resistant to 6-MP and 6-Thioguanine; NSC 755, NSC 752 (intraperitoneal) in B6D2F1 (BDF1) mice | | AID | 308 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 12 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model Osteogenic Sarcoma HE 10734 (subcutaneous) in C3AKF1 (CHKRF1) mice [AID310, Type: other] | | View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model Osteogenic Sarcoma HE 10734 (subcutaneous) in C3AKF1 (CHKRF1) mice | | AID | 310 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 13 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model C1498 Myeloid Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice [AID312, Type: other] | | View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model C1498 Myeloid Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice | | AID | 312 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 14 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model Sarcoma M5076 (intraperitoneal) in B6C3F1 mice [AID292, Type: other] | | View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model Sarcoma M5076 (intraperitoneal) in B6C3F1 mice | | AID | 292 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 15 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model P388 Leukemia resistant to Adriamycin; NSC 123127, Developed at Scr 08 (intraperitoneal) in CD2F1 (CDF1) mice [AID322, Type: other] | | View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model P388 Leukemia resistant to Adriamycin; NSC 123127, Developed at Scr 08 (intraperitoneal) in CD2F1 (CDF1) mice | | AID | 322 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 16 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model P388 Leukemia resistant to AMSA; NSC 249992 (intraperitoneal) in CD2F1 (CDF1) mice [AID324, Type: other] | | View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model P388 Leukemia resistant to AMSA; NSC 249992 (intraperitoneal) in CD2F1 (CDF1) mice | | AID | 324 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 17 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model P388 Leukemia resistant to Dihydroxy Anthracenedione; NSC 299195 (intraperitoneal) in CD2F1 (CDF1) mice [AID326, Type: other] | | View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model P388 Leukemia resistant to Dihydroxy Anthracenedione; NSC 299195 (intraperitoneal) in CD2F1 (CDF1) mice | | AID | 326 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 18 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model P388 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice [AID328, Type: other] | | View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model P388 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice | | AID | 328 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 19 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice [AID330, Type: other] | | View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice | | AID | 330 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 20 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model P388 Leukemia (intracerebral) in CD2F1 (CDF1) mice [AID334, Type: other] | | View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model P388 Leukemia (intracerebral) in CD2F1 (CDF1) mice | | AID | 334 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 21 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model P388 Leukemia resistant to Vincristine; NSC 67574 (intraperitoneal) in B6D2F1 (BDF1) mice [AID336, Type: other] | | View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model P388 Leukemia resistant to Vincristine; NSC 67574 (intraperitoneal) in B6D2F1 (BDF1) mice | | AID | 336 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 22 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model P388 Leukemia resistant to A Terephthalanilide; NSC 38280 (intraperitoneal) in B6D2F1 (BDF1) mice [AID338, Type: other] | | View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model P388 Leukemia resistant to A Terephthalanilide; NSC 38280 (intraperitoneal) in B6D2F1 (BDF1) mice | | AID | 338 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 23 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model Reticulum Cell Sarcoma (Kelley Mouse) (intraperitoneal) in CD2F1 (CDF1) mice [AID340, Type: other] | | View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model Reticulum Cell Sarcoma (Kelley Mouse) (intraperitoneal) in CD2F1 (CDF1) mice | | AID | 340 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 24 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model P388 Leukemia resistant to Adriamycin; NSC 123127, Developed at Scr 06 and 41 (intraperitoneal) in B6D2F1 (BDF1) mice [AID182, Type: other] | | View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model P388 Leukemia resistant to Adriamycin; NSC 123127, Developed at Scr 06 and 41 (intraperitoneal) in B6D2F1 (BDF1) mice | | AID | 182 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 25 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model ADJ-PC-6 (intraperitoneal) in BALB/cJ mice [AID184, Type: other] | | View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model ADJ-PC-6 (intraperitoneal) in BALB/cJ mice | | AID | 184 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 26 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model Lymphoma AKR (Transplanted) (intraperitoneal) in AKR/Lw mice [AID190, Type: other] | | View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model Lymphoma AKR (Transplanted) (intraperitoneal) in AKR/Lw mice | | AID | 190 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 27 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model B16 Melanoma (intraperitoneal) in B6D2F1 (BDF1) mice [AID192, Type: other] | | View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model B16 Melanoma (intraperitoneal) in B6D2F1 (BDF1) mice | | AID | 192 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 28 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model B16 Melanoma (subcutaneous) in B6D2F1 (BDF1) mice [AID194, Type: other] | | View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model B16 Melanoma (subcutaneous) in B6D2F1 (BDF1) mice | | AID | 194 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 29 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model P335 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice [AID224, Type: other] | | View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model P335 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice | | AID | 224 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 30 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model Ependymoblastoma (intracerebral) in B6C3F1 mice [AID226, Type: other] | | View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model Ependymoblastoma (intracerebral) in B6C3F1 mice | | AID | 226 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 31 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model Friend Virus Leukemia (Solid) (subcutaneous) in B6D2F1 (BDF1) mice [AID228, Type: other] | | View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model Friend Virus Leukemia (Solid) (subcutaneous) in B6D2F1 (BDF1) mice | | AID | 228 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 32 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model Lymphosarcoma Gardner 6C3HED (intraperitoneal) in C3H/He mice [AID230, Type: other] | | View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model Lymphosarcoma Gardner 6C3HED (intraperitoneal) in C3H/He mice | | AID | 230 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 33 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model Lymphosarcoma Gardner 6C3HED (intraperitoneal) in C3AKF1 (CHKRF1) mice [AID232, Type: other] | | View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model Lymphosarcoma Gardner 6C3HED (intraperitoneal) in C3AKF1 (CHKRF1) mice | | AID | 232 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 34 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model AK4 Lymphoid Leukemia (intraperitoneal) in C3AKF1 (CHKRF1) mice [AID236, Type: other] | | View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model AK4 Lymphoid Leukemia (intraperitoneal) in C3AKF1 (CHKRF1) mice | | AID | 236 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 35 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model P1081 Chloroleukemia (intraperitoneal) in B6D2F1 (BDF1) mice [AID246, Type: other] | | View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model P1081 Chloroleukemia (intraperitoneal) in B6D2F1 (BDF1) mice | | AID | 246 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 36 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice [AID248, Type: other] | | View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice | | AID | 248 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 37 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (subcutaneous) in B6D2F1 (BDF1) mice [AID250, Type: other] | | View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (subcutaneous) in B6D2F1 (BDF1) mice | | AID | 250 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 38 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intracerebral) in B6D2F1 (BDF1) mice [AID252, Type: other] | | View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intracerebral) in B6D2F1 (BDF1) mice | | AID | 252 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 39 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intravenous) in B6D2F1 (BDF1) mice [AID254, Type: other] | | View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intravenous) in B6D2F1 (BDF1) mice | | AID | 254 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 40 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice [AID256, Type: other] | | View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice | | AID | 256 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 41 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (subcutaneous) in CD2F1 (CDF1) mice [AID258, Type: other] | | View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (subcutaneous) in CD2F1 (CDF1) mice | | AID | 258 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 42 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model B16 Melanoma (intraperitoneal) in C57BL/6 mice [AID198, Type: other] | | View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model B16 Melanoma (intraperitoneal) in C57BL/6 mice | | AID | 198 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 43 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model B16 Melanoma (intraperitoneal) in B6C3F1 mice [AID200, Type: other] | | View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model B16 Melanoma (intraperitoneal) in B6C3F1 mice | | AID | 200 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 44 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model HT29;CX-1 Human Adenocarcinoma (MER+) (intrarenal inoculation) in NU/NU Swiss (nude) mice [AID206, Type: other] | | View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model HT29;CX-1 Human Adenocarcinoma (MER+) (intrarenal inoculation) in NU/NU Swiss (nude) mice | | AID | 206 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 45 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model HT29;CX-1 Human Adenocarcinoma (MER+) (intrarenal inoculation) in NU/NU BALB/C (nude) mice [AID208, Type: other] | | View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model HT29;CX-1 Human Adenocarcinoma (MER+) (intrarenal inoculation) in NU/NU BALB/C (nude) mice | | AID | 208 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 46 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model Colon 26 Adenocarcinoma (intraperitoneal) in CD2F1 (CDF1) mice [AID210, Type: other] | | View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model Colon 26 Adenocarcinoma (intraperitoneal) in CD2F1 (CDF1) mice | | AID | 210 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 47 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model P288 Lymphocytic Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice [AID216, Type: other] | | View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model P288 Lymphocytic Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice | | AID | 216 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 48 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model Human Lung LX-1 Xenograft (intrarenal inoculation) in NU/NU Swiss (nude) mice [AID264, Type: other] | | View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model Human Lung LX-1 Xenograft (intrarenal inoculation) in NU/NU Swiss (nude) mice | | AID | 264 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 49 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model Lewis Lung Carcinoma (subcutaneous) in B6D2F1 (BDF1) mice [AID270, Type: other] | | View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model Lewis Lung Carcinoma (subcutaneous) in B6D2F1 (BDF1) mice | | AID | 270 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 50 | [SID87150] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model Lewis Lung Carcinoma (intramuscular) in B6D2F1 (BDF1) mice [AID272, Type: other] | | View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 87150 | | CID | 2907 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model Lewis Lung Carcinoma (intramuscular) in B6D2F1 (BDF1) mice | | AID | 272 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
Chemical Probe 
Active 
Inactive 
Inconclusive 
Unspecified 
